Overview
An Evaluation of the Long-Term Safety of CSF-1 in Presbyopic Subjects
Status:
Recruiting
Recruiting
Trial end date:
2023-07-01
2023-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a 4 or 11 visit, multi-center, double-masked, vehicle-controlled study. The purpose of the study is to evaluate the long-term safety of CSF-1 compared with vehicle in presbyopic subjects.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Orasis Pharmaceuticals Ltd.
Criteria
Inclusion Criteria:- Subjects must have presbyopia
Exclusion Criteria:
- Have any contraindications to the study medications or diagnoses that would confound
the study data